by NATHAN MYHRVOLD
Most of the world’s focus on developing medicines and vaccines is aimed at rich people. Non-profit medical research is funded mostly by tax dollars—and rich countries prioritize their spending by what matters to them. For-profit medical research is even more focused on servicing the needs of those with higher incomes. Given the huge costs and risks of development, the thinking goes, why target customers with an income of only a few dollars per day?
Seed for more